Juxiang Xiao
- Co-authors
- Yuxian BaiJieer YingShukui QinGwo Fuang HoZhenggang RenBaek‐Yeol RyooRuocai XuXiaohong Chen
- Topics
- Gastric Cancer Management and Outcomes (5 papers)Cancer Immunotherapy and Biomarkers (5 papers)Pancreatic and Hepatic Oncology Research (4 papers)
- Cited by
- HepatologyOncologyGastroenterology
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Juxiang Xiao
14 papers receiving 437 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Oncology 275
- Hepatology 163
- Pulmonary and Respiratory Medicine 157
- Surgery 107
- Epidemiology 68
Countries citing papers authored by Juxiang Xiao
This map shows the geographic impact of Juxiang Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juxiang Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juxiang Xiao more than expected).
Fields of papers citing papers by Juxiang Xiao
This network shows the impact of papers produced by Juxiang Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juxiang Xiao. The network helps show where Juxiang Xiao may publish in the future.
Co-authorship network of co-authors of Juxiang Xiao
This figure shows the co-authorship network connecting the top 25 collaborators of Juxiang Xiao. A scholar is included among the top collaborators of Juxiang Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juxiang Xiao. Juxiang Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trialbreakdown → | 127 |
| 2 | 79 | |
| 3 | 75 | |
| 4 | 8 | |
| 5 | 16 | |
| 6 | 51 | |
| 7 | 17 | |
| 8 | 13 | |
| 9 | 11 | |
| 10 | 25 | |
| 11 | 4 | |
| 12 | [Role of oxidative stress and thioredoxin in gastric cancer]. | 1 |
| 13 | 11 | |
| 14 | [Expression of dihydropyrimidine dehydrogenase in human colorectal carcinoma and its clinical implications]. | 2 |
About Juxiang Xiao
Juxiang Xiao is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 440 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Hepatology (163 citations), Oncology (275 citations) and Gastroenterology (30 citations). Juxiang Xiao has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Yuxian Bai, Jieer Ying, Shukui Qin, Gwo Fuang Ho, Zhenggang Ren, Baek‐Yeol Ryoo, Ruocai Xu, Xiaohong Chen, Abby B. Siegel and Jianfeng Li. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.